These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19442369)

  • 41. High-risk human papillomavirus and cervical lymph node metastasis in patients with oropharyngeal cancer.
    Joo YH; Jung CK; Sun DI; Park JO; Cho KJ; Kim MS
    Head Neck; 2012 Jan; 34(1):10-4. PubMed ID: 21438064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
    Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral cavity and oropharyngeal squamous cell cancer: key imaging findings for staging and treatment planning.
    Trotta BM; Pease CS; Rasamny JJ; Raghavan P; Mukherjee S
    Radiographics; 2011; 31(2):339-54. PubMed ID: 21415183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Malignant tumors of the mouth cavity and oropharynx. Stage classification].
    Youssefzadeh S; Pamberger P; Baumgartner W; Becherer A; Wachter S; Burian M
    Radiologe; 1999 Jul; 39(7):513-24. PubMed ID: 10472079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MR imaging of Oral Cavity and Oropharyngeal Cancer.
    Abdel Razek AAK; Mansour M; Kamal E; Mukherji SK
    Magn Reson Imaging Clin N Am; 2022 Feb; 30(1):35-51. PubMed ID: 34802580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The usefulness of toluidine staining as a diagnostic tool for precancerous and cancerous oropharyngeal and oral cavity lesions.
    Allegra E; Lombardo N; Puzzo L; Garozzo A
    Acta Otorhinolaryngol Ital; 2009 Aug; 29(4):187-90. PubMed ID: 20161875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pitfalls in the staging of cancer of the oropharyngeal squamous cell carcinoma.
    Corey A
    Neuroimaging Clin N Am; 2013 Feb; 23(1):47-66. PubMed ID: 23199661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of Tumor Grade and Nodal Status in Oropharyngeal and Oral Cavity Squamous-cell Carcinoma Using a Radiomic Approach.
    Romeo V; Cuocolo R; Ricciardi C; Ugga L; Cocozza S; Verde F; Stanzione A; Napolitano V; Russo D; Improta G; Elefante A; Staibano S; Brunetti A
    Anticancer Res; 2020 Jan; 40(1):271-280. PubMed ID: 31892576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay.
    Tsujikawa T; Narita N; Kanno M; Takabayashi T; Fujieda S; Okazawa H
    Ann Nucl Med; 2018 May; 32(4):239-249. PubMed ID: 29488161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral cavity risk factors: experts' opinions and literature support.
    Stucken E; Weissman J; Spiegel JH
    J Otolaryngol Head Neck Surg; 2010 Feb; 39(1):76-89. PubMed ID: 20122349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proposal for a modified T-classification for oral cancer. The DOSAK.
    Howaldt HP; Frenz M; Pitz H
    J Craniomaxillofac Surg; 1993 Apr; 21(3):96-101. PubMed ID: 8491866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Introduction to the imaging and staging of cancer.
    Hudgins PA; Beitler JJ
    Neuroimaging Clin N Am; 2013 Feb; 23(1):1-7. PubMed ID: 23199658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphadenopathy: defining a palpable lymph node.
    Xu JJ; Campbell G; Alsaffar H; Brandt MG; Doyle PC; Glicksman JT; Fung K
    Head Neck; 2015 Feb; 37(2):177-81. PubMed ID: 24347005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malignant tumors of the oral cavity and oropharynx: clinical, pathologic, and radiologic evaluation.
    Weber AL; Romo L; Hashmi S
    Neuroimaging Clin N Am; 2003 Aug; 13(3):443-64. PubMed ID: 14631684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Observer error in the assessment of nodal disease in head and neck cancer.
    Alderson DJ; Jones TM; White SJ; Roland NJ
    Head Neck; 2001 Sep; 23(9):739-43. PubMed ID: 11505483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The reliability of palpation in the assessment of tumours.
    Watkinson JC; Johnston D; Jones N; Coady M; Laws D; Allen S; Hibbert J
    Clin Otolaryngol Allied Sci; 1990 Oct; 15(5):405-9. PubMed ID: 2282701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative workflow for lymph nodes staging.
    Botturi D; Pizzorni Ferrarese F; Zamboni GA; Zerbato D
    Int J Comput Assist Radiol Surg; 2009 Jan; 4(1):99-104. PubMed ID: 20033607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome assessment in oral and oropharyngeal cancers.
    Dwivedi RC; Roe JW; Kazi RA; Clarke PM; Kerawala CJ; Rhys-Evans PH
    J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):215; author reply 216. PubMed ID: 20470663
    [No Abstract]   [Full Text] [Related]  

  • 59. Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms. Association of Directors of Anatomic and Surgical Pathology.
    Zarbo RJ; Barnes L; Crissman JD; Gnepp DR; Mills SE
    Hum Pathol; 2000 Oct; 31(10):1191-3. PubMed ID: 11203319
    [No Abstract]   [Full Text] [Related]  

  • 60. Lateness of diagnosis of oral and oropharyngeal carcinoma: factors related to the tumour, the patient and health professionals.
    Kowalski LP; Franco EL; Torloni H; Fava AS; de Andrade Sobrinho J; Ramos G; Oliveira BV; Curado MP
    Eur J Cancer B Oral Oncol; 1994 May; 30B(3):167-73. PubMed ID: 7920162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.